Innovating patient journeys with AI solutions to reduce potentially avoidable hospitalizations
Healthcare innovators and technology experts explored, during a roundtable hosted by Nebius, AstraZeneca, and NVIDIA, opportunities for health systems to strengthen care delivery and minimize Potentially Avoidable Hospitalizations (PAHs) through AI.
This whitepaper highlights expert perspectives on how expanding medical data and AI capabilities enable clinicians and nurses to scale guideline-directed medical therapy (GDMT) throughout patient journeys and reduce PAHs.
Discover perspectives on:
AI’s ability to help healthcare providers tailor treatments and expand specialist expertise to frontline teams through case-specific analytics and clinically validated agentic and generative solutions.
Opportunities to accelerate implementation by overcoming challenges related to data availability, clinical adoption, system-wide incentives, and regulatory clarity.
Strategies for health systems, pharmaceutical leaders, technology companies, and policymakers to work together and advance AI-powered disease management.